| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $545.7M | — | -0.9% |
| Cost of Revenue | $292.2M | — | -5.6% |
| Gross Profit | $253.5M | — | +5.0% |
| R&D Expense | $59.8M | — | -26.1% |
| SG&A Expense | $28.0M | — | +8.4% |
| Operating Income | $100.4M | — | +108.8% |
| Pre-tax Income | $102.1M | — | +133.0% |
| Income Tax | $8.3M | — | +228.8% |
| Net Income | $93.8M | — | +86.7% |
| EPS (Basic) | $0.78 | — | +90.2% |
| EPS (Diluted) | $0.75 | — | +87.5% |
| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $312.5M | +78.9% | +11.6% |
| Accounts Receivable | $116.3M | +76.6% | +37.1% |
| Inventory | $125.3M | -26.7% | -11.0% |
| Current Assets | $640.2M | +27.0% | +4.5% |
| Total Assets | $947.9M | +15.1% | -1.6% |
| Current Liabilities | $388.2M |
| Line Item | 2025-12-27 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $163.3M | — | +4.6% |
| Capital Expenditures | $6.0M | — | -54.5% |
| Investing Cash Flow | -$4.1M | — | +56.5% |
| Financing Cash Flow | -$23.4M | — | +30.7% |
| Free Cash Flow | $157.3M | — | +10.0% |
| +4.2% |
| Total Liabilities | $504.5M | +7.8% | +2.0% |
| Stockholders' Equity | $443.3M | +24.8% | -5.5% |